Four studies met all of the criteria of the quality- assessment tool, and some adjustments were made for potential confounding factors, such as age, BMI, family history of diabetes, HOMA-IR, HCV genotype, HCVRNA levels, AST, ALT, and cirrhosis. The gene discussed is GPT; the disease is diabetes mellitus.